SULLIVAN GREGORY M 5
5 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 11, 2022
Insider Transaction Report
Form 5
SULLIVAN GREGORY M
Chief Medical Officer
Transactions
- Award
Common Stock, par value $0.001
2021-06-30$0.58/sh+36,496$21,168→ 99,223 total
Footnotes (1)
- [F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan.